Diabetes type 1 vaccine - Corixa

Drug Profile

Diabetes type 1 vaccine - Corixa

Alternative Names: Anervax.DB; DiavaX

Latest Information Update: 04 Nov 2002

Price : $50

At a glance

  • Originator Corixa Corporation
  • Class Antihyperglycaemics; Diabetes mellitus vaccines; Vaccines
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Type 1 diabetes mellitus

Most Recent Events

  • 04 Nov 2002 Discontinued - Preclinical for Type-1 diabetes mellitus in USA (unspecified route)
  • 12 May 2000 Anervax.DBTM is available for licensing (http://www.corixa.com)
  • 23 Feb 1999 Anergen is now part of Corixa Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top